Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

02:13 PM EDT, 09/28/2026 (MT Newswires) -- Eli Lilly (LLY) plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg News reported Monday, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly didn't immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 1186.63, Change: +3.16, Percent Change: +0.27